Jia Hao

684 total citations
25 papers, 467 citations indexed

About

Jia Hao is a scholar working on Molecular Biology, Finance and Accounting. According to data from OpenAlex, Jia Hao has authored 25 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Finance and 7 papers in Accounting. Recurrent topics in Jia Hao's work include Corporate Finance and Governance (7 papers), Financial Markets and Investment Strategies (7 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Jia Hao is often cited by papers focused on Corporate Finance and Governance (7 papers), Financial Markets and Investment Strategies (7 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Jia Hao collaborates with scholars based in China, Hong Kong and United States. Jia Hao's co-authors include Xueyuan Xiao, Dacheng He, Anjian Xu, Tian Tian, Chuanjun Liu, Lingyun Huang, Hendrik Bessembinder, Zhongqin Gong, George G. Chen and Jianwei Ren and has published in prestigious journals such as Review of Financial Studies, Annals of Oncology and Signal Transduction and Targeted Therapy.

In The Last Decade

Jia Hao

25 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jia Hao China	12	250	105	96	79	65	25	467
Hideki Kanda Japan	15	169 0.7×	54 0.5×	114 1.2×	22 0.3×	50 0.8×	73	693
Eunho Cho United States	15	207 0.8×	69 0.7×	78 0.8×	57 0.7×	12 0.2×	40	615
Howard Chan Australia	16	192 0.8×	68 0.6×	97 1.0×	26 0.3×	309 4.8×	30	742
Xiaoqian Zhang China	14	163 0.7×	87 0.8×	83 0.9×	26 0.3×	39 0.6×	19	515
Ricardo Coelho Switzerland	14	177 0.7×	90 0.9×	118 1.2×	66 0.8×	92 1.4×	29	649
Rui Fan China	17	680 2.7×	329 3.1×	141 1.5×	60 0.8×	11 0.2×	60	998
Yu Kyung Lee South Korea	8	77 0.3×	71 0.7×	143 1.5×	44 0.6×	13 0.2×	22	315
Chen Lin China	9	95 0.4×	86 0.8×	115 1.2×	27 0.3×	20 0.3×	20	325
Dennis Botman United States	12	254 1.0×	118 1.1×	25 0.3×	13 0.2×	86 1.3×	50	620
Yuchen Sun Japan	13	234 0.9×	147 1.4×	95 1.0×	9 0.1×	15 0.2×	31	452

Countries citing papers authored by Jia Hao

Since Specialization

Citations

This map shows the geographic impact of Jia Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Hao more than expected).

Fields of papers citing papers by Jia Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Hao. The network helps show where Jia Hao may publish in the future.

Co-authorship network of co-authors of Jia Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Hao. A scholar is included among the top collaborators of Jia Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Hao. Jia Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Qi, Juan Liu, Ming Yang, et al.. (2025). Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma. Signal Transduction and Targeted Therapy. 10(1). 244–244. 4 indexed citations

Chen, Dong, Xi Su, Jia Hao, et al.. (2023). Papillary thyroid cancer organoids harboring BRAFV600E mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies. Journal of Translational Medicine. 21(1). 9–9. 28 indexed citations

Su, Xi, Dong Chen, Jia Hao, et al.. (2022). SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition. Cell Death and Disease. 13(3). 218–218. 12 indexed citations

Su, Xi, Peng Li, Bin Han, et al.. (2021). Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032. Journal of Experimental & Clinical Cancer Research. 40(1). 34–34. 22 indexed citations

Wu, Wenying, et al.. (2021). MiR-9 promotes proliferation and inhibits apoptosis of bladder cancer cells via notch signaling pathway. Panminerva Medica. 65(1). 114–115. 1 indexed citations

Le, Kang, Jia Hao, Ben Huang, et al.. (2021). Identification of Differently Expressed mRNAs in Atherosclerosis Reveals CDK6 Is Regulated by circHIPK3/miR-637 Axis and Promotes Cell Growth in Human Vascular Smooth Muscle Cells. Frontiers in Genetics. 12. 596169–596169. 24 indexed citations

Gong, Zhongqin, Jia Hao, Dongcai Li, et al.. (2021). The emerging role of transcription factor FOXP3 in thyroid cancer. Reviews in Endocrine and Metabolic Disorders. 23(3). 421–429. 9 indexed citations

Yu, Peter S. Y., et al.. (2020). Surgical access trauma following minimally invasive thoracic surgery. European Journal of Cardio-Thoracic Surgery. 58(Supplement_1). i6–i13. 8 indexed citations

Gong, Zhongqin, Jia Hao, Jianqing Yu, et al.. (2020). Nuclear FOXP3 inhibits tumor growth and induced apoptosis in hepatocellular carcinoma by targeting c-Myc. Oncogenesis. 9(10). 97–97. 24 indexed citations

10.

Hao, Jia, et al.. (2019). FOXP3Δ3, the major isoform of FOXP3, promotes proliferation, migration, and invasion in non-small cell lung cancer. Annals of Oncology. 30. ii5–ii6. 2 indexed citations

11.

Bessembinder, Hendrik, et al.. (2019). Liquidity Provision Contracts and Market Quality: Evidence from the New York Stock Exchange. Review of Financial Studies. 33(1). 44–74. 23 indexed citations

12.

Hao, Jia, Haolong Qi, Zhongqin Gong, et al.. (2019). The expression of FOXP3 and its role in human cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(1). 170–178. 51 indexed citations

13.

Hao, Jia, et al.. (2012). Competition in Make-Take Fees in the U.S. Equity Market. SSRN Electronic Journal. 9 indexed citations

14.

Wang, Ke, Yue Yang, Tian Tian, et al.. (2011). Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells. Molecular and Cellular Biochemistry. 359(1-2). 323–332. 41 indexed citations

15.

Xu, Anjian, Jia Hao, Zhao Zhang, et al.. (2009). 14-kDa phosphohistidine phosphatase and its role in human lung cancer cell migration and invasion. Lung Cancer. 67(1). 48–56. 38 indexed citations

16.

Hao, Jia, Avner Kalay, & Stewart Mayhew. (2009). Ex-dividend Arbitrage in Option Markets. Review of Financial Studies. 23(1). 271–303. 18 indexed citations

17.

Hao, Jia, Anjian Xu, Xiaolei Xie, et al.. (2008). Elevated Expression of UBE2T in Lung Cancer Tumors and Cell Lines. Tumor Biology. 29(3). 195–203. 36 indexed citations

18.

Lv, Wei, Chao Zhang, Jia Hao, et al.. (2007). RNAi-Mediated Gene Silencing of Vascular Endothelial Growth Factor Inhibits Growth of Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 22(6). 841–852. 3 indexed citations

19.

Tian, Tian, Jia Hao, Anjian Xu, et al.. (2007). Determination of metastasis‐associated proteins in non‐small cell lung cancer by comparative proteomic analysis. Cancer Science. 98(8). 1265–1274. 71 indexed citations

20.

Tian, Tian, Jia Hao, Jifu Liu, et al.. (2007). Elevation of Serum HSP90α Correlated with the Clinical Stage of Non-Small Cell Lung Cancer. 3(4). 107–112. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact